Sign Out
This drug should be used on pregnant or possibly pregnant women only if the anticipated therapeutic benefit is thought to outweigh any potential risk. (The safety of this drug in pregnant women has not been established.)
Nursing should be interrupted when this drug is administered to a nursing woman. (Rat studies showed Rebamipide is distributed in the breast milk.)
Continue with Google